The conversation highlights the evolving landscape where leading experts in computer science and molecular biology are increasingly fluent in each other's languages. This shift presents a unique opportunity for investment firms to bridge the gap between software and biotech, enabling the creation of innovative businesses that reflect this convergence. The emphasis is on the need for a rallying call within the ecosystem to support and nurture emerging entrepreneurs.
